Journal of Clinical Lipidology
Volume 2, Issue 4 , Pages 274-278, August 2008

Plasma lipids in Nigerians with systemic arterial hypertension

  • Kamilu K. Karaye, MBBS, MSc

      Affiliations

    • Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria
  • ,
  • Basil N. Okeahialam, MBBS

      Affiliations

    • Department of Medicine, Jos University Teaching Hospital, 3 Murtala Muhammed Way, Jos, Plateau 930001, Nigeria
    • Corresponding Author InformationCorresponding author.
  • ,
  • Sadiq S. Wali, MBBS

      Affiliations

    • Department of Medicine, Murtala Muhammed Specialist Hospital, Kano, Nigeria

Received 6 November 2007; accepted 17 March 2008. published online 25 March 2008.

Background

In a nationwide survey of Nigeria, residents of Kano were shown to have the highest prevalence of hypertension and the highest levels of plasma cholesterol. Because hypertension and high cholesterol together markedly increase the risk for cardiovascular disease, we examined lipid profiles among hypertensives and nonhypertensives in Kano. To determine the extent to which there were differences in lipid profiles based on therapy for blood pressure, we created three strata for comparison.

Methods

The study was conducted at Aminu Kano Teaching Hospital, Kano, Nigeria. Lipid levels were examined among randomly selected hypertensives on antihypertensive regimens (n = 70), treatment-naïve hypertensives (n = 70), and normotensive individuals (n = 70) matched for age and gender. Overall mean age for hypertensives was 50.5 ± 11.9 years, and 54.3% were female. For the control group, mean age was 49.3 ± 12.9 years, and 55.7% were female.

Results

Mean total cholesterol of the hypertensives on therapy (group 1) was 5.69 ± 1.19 mmol/L. Total cholesterol was significantly higher than levels in the treatment-naïve hypertensives (group 2) (5.24 ± 0.76 mmol/L; P = 0.01) and the controls (group 3) (4.91 ± 0.72 mmol/L; P = 0.000). Significant differences were also evident between groups for low-density lipoprotein (LDL) cholesterol. For high-density lipoprotein (HDL) cholesterol, the difference between the hypertensives on therapy and the treatment-naïve was not significant. Difference in this index between each hypertensive group and control was significant. The difference between groups for triglycerides followed the same pattern as HDL cholesterol. Increased total cholesterol (>6.5 mmol/L) was found to be 20%, 4.4%, and 1.4% in the hypertensive on therapy, treatment-naïve hypertensive, and control groups, respectively.

Conclusion

High levels of total and LDL cholesterol were more prevalent in treated versus untreated hypertensives and normotensive individuals, suggesting co-occurrence of two important risk factors for cardiovascular disease that is not ameliorated by treatment for hypertension.

Keywords: Hypertension, Lipids, Nigerians, Plasma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1933-2874(08)00125-6

doi:10.1016/j.jacl.2008.03.002

Journal of Clinical Lipidology
Volume 2, Issue 4 , Pages 274-278, August 2008